These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 92342)

  • 1. Studies on the activation of canine trypsinogens in vitro.
    Borgström A; Ohlsson K
    Biochim Biophys Acta; 1979 Dec; 571(2):284-93. PubMed ID: 92342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies on the mechanism of activation of the two human trypsinogens.
    Colomb E; Figarella C
    Biochim Biophys Acta; 1979 Dec; 571(2):343-51. PubMed ID: 508771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to human pancreatic trypsin 1 inhibit the activation of human trypsinogens 1 and 2.
    Guy-Crotte O; Miszczuk-Jamska B; Brayle A; Lafont P; Figarella C
    Eur J Biochem; 1992 Feb; 204(1):133-6. PubMed ID: 1371252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera.
    Brodrick JW; Geokas MC; Largman C; Fassett M; Johnson JH
    Am J Physiol; 1979 Nov; 237(5):E474-80. PubMed ID: 91323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behaviour of serum immunoreactive trypsin after serum activation by enterokinase in normal and cystic fibrosis patients. Evidence of a trypsin-alpha 1-proteinase inhibitor complex in some cystic fibrosis patients.
    Carrère J; Chazalette JP; Figarella C
    Biochim Biophys Acta; 1989 Dec; 993(2-3):137-42. PubMed ID: 2480820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 1-antitrypsin and alpha 2-macroglobulin do not inhibit the kinin-releasing activity of kallikreins from human urine and saliva.
    Sakamoto W; Nishikaze O
    Biochim Biophys Acta; 1980 Dec; 633(3):305-9. PubMed ID: 6163451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cationic proteins of human granulocytes. V. Interaction with plasma protease inhibitors.
    Venge P; Olsson I; Odeberg H
    Scand J Clin Lab Invest; 1975 Dec; 35(8):737-44. PubMed ID: 54932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of trypsinogens 1 and 2 in two human pancreatic adenocarcinoma cell lines; CFPAC-1 and CAPAN-1.
    Miszczuk-Jamska B; Merten M; Guy-Crotte O; Amouric M; Clemente F; Schoumacher RA; Figarella C
    FEBS Lett; 1991 Dec; 294(3):175-8. PubMed ID: 1756857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fate of intravenously injected trypsinogens in dogs.
    Borgström A
    Scand J Gastroenterol; 1981; 16(2):281-7. PubMed ID: 7313540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effect of heparin on trypsinogen activation with enterokinase.
    Wolosowicz N; Prokopowicz J; Gabryelewicz A
    Acta Hepatogastroenterol (Stuttg); 1977 Oct; 24(5):368-71. PubMed ID: 930538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the role of the plasma protease inhibitors on in vitro C3 activation and in acute pancreatitis.
    Balldin G; Eddeland A; Ohlsson K
    Scand J Gastroenterol; 1981; 16(5):603-9. PubMed ID: 6172839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive trypsins in sera from dogs before and after induction of experimental pancreatitis.
    Borgström A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):625-31. PubMed ID: 6159294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The two human trypsinogens. Evidence of complex formation with basic pancreatic trypsin inhibitor-proteolytic activity.
    Colomb E; Figarella C; Guy O
    Biochim Biophys Acta; 1979 Oct; 570(2):397-405. PubMed ID: 40607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactive forms of cationic trypsin in plasma and ascitic fluid of dogs in experimental pancreatitis.
    Geokas MC; Largman C; Durie PR; Brodrick JW; Ray SB; O'Rourke M; Vollmer J
    Am J Pathol; 1981 Oct; 105(1):31-9. PubMed ID: 6170231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute pancreatitis in Soweto, South Africa: relationship between trypsinogen load, trypsinogen activation, and fibrinolysis.
    Segal I; Chaloner C; Douglas J; John KD; Zaidi A; Cotter L; Appelros S; Borgström A; Braganza JM
    Am J Gastroenterol; 2002 Apr; 97(4):883-92. PubMed ID: 12003423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of alpha1-antitrypsin and alpha-macroglobulins in the uptake of proteinase by rabbit alveolar macrophages.
    Dolovich J; Debanne MT; Bell R
    Am Rev Respir Dis; 1975 Oct; 112(4):521-5. PubMed ID: 54012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases.
    Kukor Z; Tóth M; Sahin-Tóth M
    Eur J Biochem; 2003 May; 270(9):2047-58. PubMed ID: 12709065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the potential role of trypsin and trypsin inhibitors in acute pancreatitis.
    Lasson A; Ohlsson K
    Adv Exp Med Biol; 1984; 167():477-87. PubMed ID: 6201050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay.
    Geokas MC; Largman C; Brodrick JW; Johnson JH
    Am J Physiol; 1979 Jan; 236(1):E77-83. PubMed ID: 434151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The action of potato inhibitors on activation of zymogen forms of digestive system proteases.
    Worowski K; Gabryelewicz A; Roszkowska W; Bajko K
    Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):413-6. PubMed ID: 525219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.